ArticleActa pharmacologica Sinica2026

HDAC inhibitor GCJ-490A modulates tumor microenvironment and synergizes with PD-1 antibody against breast and lung cancers in syngeneic murine models.

Wen-Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.